NPI: 1245667229 · HANCOCK, MI 49930 · General Acute Care Hospital · NPI assigned 10/04/2013
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 10/04/2013 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 38,930 | $757K |
| 2019 | 35,061 | $723K |
| 2020 | 29,842 | $652K |
| 2021 | 39,097 | $991K |
| 2022 | 38,319 | $982K |
| 2023 | 38,882 | $935K |
| 2024 | 31,977 | $808K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,278 | 3,926 | $1.37M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 6,878 | 6,536 | $872K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,748 | 3,555 | $735K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 10,528 | 3,796 | $310K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,212 | 2,036 | $213K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 5,139 | 1,922 | $210K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4,451 | 1,812 | $164K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,259 | 2,181 | $159K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,054 | 1,020 | $156K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,566 | 1,130 | $152K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,685 | 1,083 | $102K |
| 71046 | Radiologic examination, chest; 2 views | 2,363 | 2,263 | $88K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,344 | 1,842 | $76K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,969 | 1,729 | $65K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,461 | 1,402 | $64K |
| 84443 | Thyroid stimulating hormone (TSH) | 8,350 | 8,066 | $60K |
| 80053 | Comprehensive metabolic panel | 18,293 | 16,272 | $59K |
| 70450 | Computed tomography, head or brain; without contrast material | 656 | 632 | $58K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3,465 | 1,277 | $58K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,421 | 1,243 | $57K |
| 80061 | Lipid panel | 5,079 | 5,062 | $57K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 21,526 | 18,762 | $52K |
| 36415 | Collection of venous blood by venipuncture | 29,889 | 25,374 | $49K |
| 71045 | Radiologic examination, chest; single view | 1,032 | 981 | $40K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,664 | 1,632 | $29K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,608 | 1,576 | $28K |
| 41899 | Unlisted procedure, dentoalveolar structures | 12 | 12 | $28K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,065 | 1,033 | $27K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,840 | 1,827 | $24K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 13 | 13 | $22K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 286 | 285 | $22K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 1,349 | 1,344 | $21K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,829 | 3,805 | $19K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 666 | 646 | $18K |
| 97162 | 338 | 336 | $18K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 341 | 339 | $16K |
| 84439 | 3,526 | 3,467 | $16K | |
| 86900 | 517 | 488 | $15K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 999 | 977 | $15K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,695 | 4,314 | $13K |
| 82728 | 2,036 | 1,937 | $13K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 228 | 222 | $12K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 663 | 659 | $12K |
| 87088 | 4,106 | 3,768 | $12K | |
| 87186 | 2,460 | 2,341 | $11K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 89 | 80 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,394 | 2,001 | $9K |
| 76801 | 159 | 151 | $9K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 117 | 117 | $9K |
| 87806 | 944 | 924 | $9K | |
| 76830 | Ultrasound, transvaginal | 145 | 139 | $8K |
| 73610 | 364 | 320 | $8K | |
| 83655 | 1,016 | 1,002 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,562 | 2,327 | $7K |
| 87081 | 2,460 | 2,406 | $7K | |
| 82607 | 948 | 939 | $7K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 92 | 52 | $6K |
| 81001 | 8,691 | 7,952 | $6K | |
| 86803 | 1,291 | 1,279 | $6K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 44 | 43 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,874 | 1,730 | $5K |
| 87070 | 1,563 | 1,498 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,177 | 1,153 | $5K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 990 | 870 | $5K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 12 | 12 | $5K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 12 | 12 | $5K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 98 | 84 | $4K |
| 85027 | 1,615 | 1,486 | $4K | |
| 86850 | 594 | 570 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 308 | 308 | $4K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 62 | 62 | $4K |
| 73630 | 230 | 219 | $4K | |
| 80305 | 1,289 | 1,079 | $3K | |
| 97161 | 64 | 64 | $3K | |
| 82570 | 1,257 | 1,189 | $3K | |
| 73110 | 108 | 85 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,020 | 593 | $3K |
| 86140 | 1,569 | 1,508 | $3K | |
| 73562 | 107 | 99 | $2K | |
| 83735 | 3,884 | 3,461 | $2K | |
| 86592 | 815 | 803 | $2K | |
| 85652 | 2,082 | 2,027 | $2K | |
| 73130 | 114 | 85 | $2K | |
| 87340 | 816 | 805 | $2K | |
| 85610 | 2,095 | 1,762 | $2K | |
| 84481 | 204 | 200 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 29 | 29 | $2K |
| 82043 | 533 | 533 | $2K | |
| 0012A | 45 | 45 | $2K | |
| 83540 | 455 | 447 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 47 | 45 | $1K |
| 84703 | 3,229 | 2,995 | $1K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 12 | 12 | $1K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 12 | 12 | $1K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 200 | 200 | $1K |
| 87077 | 312 | 296 | $1K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 12 | 12 | $1K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 198 | 192 | $1K |
| 83690 | 2,009 | 1,837 | $1K | |
| 74019 | 70 | 67 | $1K | |
| 0011A | 70 | 61 | $922.95 | |
| 73030 | 47 | 40 | $891.84 | |
| 84702 | 144 | 107 | $761.53 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 13 | 13 | $757.37 |
| 84145 | 1,155 | 1,047 | $755.85 | |
| 86038 | 174 | 174 | $711.18 | |
| 82950 | 255 | 253 | $696.84 | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 89 | 82 | $686.03 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 544 | 481 | $605.87 |
| 85730 | 814 | 769 | $471.75 | |
| 87581 | 44 | 43 | $460.56 | |
| 87486 | 44 | 43 | $460.56 | |
| 87210 | 194 | 188 | $438.15 | |
| 83550 | 96 | 96 | $420.21 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 12 | 12 | $419.40 |
| 72100 | 15 | 15 | $387.88 | |
| 86756 | 138 | 130 | $382.78 | |
| 83615 | 201 | 170 | $343.51 | |
| 85378 | 207 | 200 | $236.70 | |
| 73502 | 13 | 13 | $220.67 | |
| 83880 | 26 | 24 | $206.18 | |
| 86704 | 38 | 38 | $204.67 | |
| 84484 | 1,515 | 1,295 | $190.38 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 216 | 174 | $166.34 |
| 88304 | 27 | 13 | $154.90 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,105 | 2,022 | $106.24 |
| 83605 | 1,807 | 1,635 | $98.69 | |
| 82550 | 209 | 183 | $91.20 | |
| 82077 | 731 | 654 | $90.79 | |
| 82652 | 13 | 13 | $45.82 | |
| 86430 | 13 | 13 | $34.30 | |
| 86431 | 26 | 26 | $34.28 | |
| 82042 | 12 | 12 | $29.82 | |
| 80076 | 16 | 14 | $24.30 | |
| 84550 | 16 | 14 | $15.84 | |
| 80143 | 298 | 274 | $10.40 | |
| 86762 | 13 | 13 | $9.04 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,274 | 2,992 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 324 | 316 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 335 | 317 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 2,385 | 2,321 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,297 | 1,178 | $0.00 |
| 86901 | 516 | 488 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 804 | 777 | $0.00 |
| 0240U | 647 | 630 | $0.00 | |
| A9270 | Non-covered item or service | 617 | 522 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 40 | 40 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 88 | 79 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 43 | 40 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,742 | 2,525 | $0.00 |
| 80179 | 294 | 272 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 13 | 13 | $0.00 |
| 99001 | 14 | 13 | $0.00 |